Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXtract Regulatory News (XTR)

Share Price Information for Xtract (XTR)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.15 (13.64%)
Bid:
1.20
Ask:
1.30
Spread: 0.10 (8.333%)
Market Cap: £10.70m
XTR Live PriceLast checked at - London Stock Exchange

Intraday Xtract Share Chart

Application update

22 Nov 2022 12:21

RNS Number : 2357H
Xtract Resources plc
22 November 2022
 

 

For immediate release

 22 November 2022

Xtract Resources Plc

("Xtract" or the "Company")

Application update

 

The Board of Xtract announces that application to trading on AIM on or around 29 November 2022 ("Admission") has now been made for 5,362,229 new Ordinary Shares issued at a price of 3.23p per Ordinary Share, issued in settlement of accrued outstanding remuneration in relation to 2021, due to certain Directors and employees of the Company ("Settlement Shares") and the issue of 619,195 new Ordinary Shares ("Creditor Settlement Shares") issued at a price of 3.23p per Ordinary share, in aggregate amounting to 5,981,424 new Ordinary Shares ("New Shares"), as announced on 4 November 2022. The New Shares will rank pari passu in all respects with the Company's existing issued ordinary shares.

 

Total Voting Rights

On Admission, the Company's issued share capital consists of 856,375,115 ordinary shares of 0.02p each with voting rights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights is 856,375,115. The above figure of 856,375,115 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

A copy of this announcement: www.xtractresources.com

 

Enquiries:

Xtract Resources Plc

Colin Bird,

Executive Chairman

 

+44 (0)20 3416 6471

www.xtractresources.com

Beaumont Cornish Limited

Nominated Adviser and Joint Broker

Roland Cornish

Michael Cornish

Felicity Geidt

+44 (0)207628 3369

www.beaumontcornish.co.uk

 

Novum Securities Limited

Joint Broker

 

Jon Bellis

Colin Rowbury 

 

+44 (0)207 399 9427

www.novumsecurities.com  

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPGPGGUPPGPP
Date   Source Headline
2nd Mar 20227:00 amRNSBushranger Project drilling update
28th Feb 20224:40 pmRNSSecond Price Monitoring Extn
28th Feb 20224:36 pmRNSPrice Monitoring Extension
28th Feb 202212:56 pmRNSBushranger Project MIMDAS geophysical survey
10th Feb 20221:30 pmRNSBushranger Project Assay Results
3rd Feb 20222:30 pmRNSBushranger Project Assay Results
28th Jan 202212:04 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSMetallurgical test work planned at Bushranger
19th Jan 20223:45 pmRNSBushranger Project Assay Results
18th Jan 20227:00 amRNSManica Gold Update
6th Jan 202211:39 amRNSDirectorate Change
4th Jan 20224:41 pmRNSSecond Price Monitoring Extn
4th Jan 20224:36 pmRNSPrice Monitoring Extension
4th Jan 20222:06 pmRNSSecond Price Monitoring Extn
4th Jan 20222:00 pmRNSPrice Monitoring Extension
4th Jan 202211:05 amRNSSecond Price Monitoring Extn
4th Jan 202211:00 amRNSPrice Monitoring Extension
21st Dec 20217:00 amRNSBushranger Project Assay Results
17th Dec 20211:41 pmRNSBushranger Project Phase 2 Drilling Update
9th Dec 20212:53 pmRNSNew Porphyry Copper System at Bushranger Project
2nd Dec 20217:00 amRNSBushranger Project Drilling Update
24th Nov 20217:00 amRNSBushranger Project Assay Results
19th Nov 202111:42 amRNSBushranger assay results and drilling update
12th Nov 202110:25 amRNSBushranger Project Assay Results
9th Nov 202112:30 pmRNSBushranger Project Phase 2 Drilling Update
2nd Nov 20219:07 amRNSBushranger Project Phase 2 Drilling Update
29th Oct 20217:00 amRNSBushranger Project Further Assay Results
25th Oct 20215:29 pmRNSResult of AGM
21st Oct 20212:42 pmRNSBushranger Project Assay Results
20th Oct 20212:10 pmRNSBushranger Phase 2 Drilling Programme Update
14th Oct 20217:00 amRNSManica Gold Update
13th Oct 20217:00 amRNSBushranger drilling and licence update
7th Oct 20216:06 pmRNSBushranger Project Assay Results
7th Oct 202110:01 amRNSBushranger Phase 2 Drilling Programme Update
5th Oct 20217:00 amRNSManica Alluvial Gold Update Notice of AGM
1st Oct 202111:30 amRNSNotice of AGM
30th Sep 20212:50 pmRNSHalf-year Report
28th Sep 20217:00 amRNSBushranger Assay Results and Drilling Update
22nd Sep 20217:00 amRNSFurther Bushranger Drilling Programme Update
20th Sep 20213:32 pmRNSEureka Phase 2 Drilling Final Assay Results
14th Sep 202111:43 amRNSFurther Drilling Progress Update at Bushranger
14th Sep 20217:00 amRNSEureka Copper Project - Phase 2 drilling update
2nd Sep 20211:22 pmRNSFurther drilling progress update at Bushranger
23rd Aug 20212:59 pmRNSDirector/PDMR Shareholding
20th Aug 202110:55 amRNSDirectorate Change
19th Aug 202112:49 pmRNSFurther drilling progress update at Bushranger
12th Aug 20217:00 amRNSBushranger drilling update and licence renewal
4th Aug 20212:11 pmRNSDirectorate Change
2nd Aug 20219:00 amRNSBushranger phase two drilling update
29th Jul 202111:39 amRNSPhase Two Drilling Update at Bushranger

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.